Screening tests during prenatal care: does practice follow the evidence?

Area of Science:

• Obstetrics and Gynecology
• Preventive Medicine
• Health Services Research

Background:

• Prenatal care guidelines recommend specific screening tests to ensure maternal and fetal health.
• The frequency of these tests can vary, potentially leading to underuse or overuse of evidence-based practices.

Purpose of the Study:

• To evaluate the adherence of four key prenatal screening tests—urine culture, anemia screening, oral glucose tolerance test (OGTT), and urinalysis—to evidence-based recommendations.
• To identify disparities in screening test utilization among different demographic groups.

Main Methods:

• Utilized national probability samples from the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey (2001-2006).
• Estimated the rates of four screening tests during prenatal care.
• Compared observed screening rates against U.S. Preventive Services Task Force (USPSTF) recommendations.

Main Results:

• Urine cultures were performed in less than half of pregnancies, indicating underuse.
• Anemia screening rates closely matched USPSTF recommendations, averaging just over one screening per pregnancy.
• Urinalysis rates were high, averaging 5.6 per pregnancy (2001-2003) decreasing to 4.3 (2004-2006).
• Oral glucose tolerance tests (OGTT) were performed in nearly all pregnancies, despite no universal recommendation from USPSTF.
• Minority and older women received more anemia screenings, urine cultures, and OGTTs compared to white and younger women.

Conclusions:

• Significant deviations exist between recommended and actual frequencies of prenatal screening tests.
• There is a need to increase the utilization of urine cultures and decrease the frequency of urinalyses during prenatal care.
• Anemia screening aligns with guidelines, while OGTT is routinely performed without a universal recommendation, highlighting areas for practice improvement.